Related Experiment Videos
Peripheral T-cell subsets in asymptomatic hepatitis B-virus carriers
Cellular Immunology
|April 1, 1986
Summary
T-cell subset abnormalities in chronic hepatitis B virus (HBV) infection are linked to hepatitis B e antigen (HBeAg) status, not liver damage. These immune changes may precede liver disease, suggesting an underlying immunological issue in HBV carriers.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Circulating T-cell subset abnormalities are observed in chronic liver diseases.
- It remains unclear if these immune changes are a cause or consequence of liver disease.
Purpose of the Study:
- To investigate whether T-cell subset abnormalities in hepatitis B virus (HBV)-related chronic liver disease are primary or secondary.
- To analyze T-cell subsets in asymptomatic HBV carriers and compare them with patients with chronic active liver disease.
Main Methods:
- Peripheral T-cell subsets (OKT3, OKT4, OKT8) were analyzed using indirect immunofluorescence.
- Study included 30 asymptomatic HBV carriers (15 HBeAg-positive, 15 anti-HBe-positive) and 15 patients with chronic active liver disease.
Main Results:
- Reduced OKT4/OKT8 ratios were found in HBeAg-positive asymptomatic carriers, with decreased OKT4 and increased OKT8 cells.
- T-cell subsets and ratios were normal in anti-HBe-positive asymptomatic carriers.
- T-cell subset changes in HBeAg-positive carriers mirrored those in HBeAg-positive patients with chronic active liver disease.
Conclusions:
- Deranged T-cell subsets in chronic HBV infection appear to be an underlying immunological abnormality related to HBeAg/anti-HBe status, not secondary to liver damage.
- The pathogenesis of liver damage in chronic HBV infection may involve factors beyond circulating T-cell subsets.